Vivor CEO highlights affected person monetary help platform for hospitals and well being techniques


Vivor CEO and co-founder Ian Manners talks concerning the origins of the financial assistance startup and their mission to get rid of out-of-pocket prices as a barrier to care.

Why did you begin this firm?

In my earlier profession as a administration marketing consultant, I labored with quite a lot of pharma corporations that have been making an attempt to determine all of the the explanation why sufferers may not have the ability to begin or proceed therapy for life-threatening situations like most cancers. In fact, most of those causes have been scientific ones — critical unwanted effects, for instance — however I used to be actually shocked how usually the non-clinical considerations like out-of-pocket value have been inflicting sufferers to skip or delay care. 

What I found was that insured sufferers are sometimes requested to shoulder a good portion of the price of clinically applicable, life-saving therapy. However on the identical time, there are an unlimited variety of help sources on the market — from pharma corporations and non-profit foundations, primarily — which might be really going underused. For instance, in most cancers therapy, solely about 1 in 5 eligible sufferers get entry to sources that might considerably cut back their out-of-pocket prices. I figured there needed to be a solution to shut this hole, and I believed strongly that expertise was an enormous a part of the answer.

What particular want are you searching for to handle in healthcare?

Vivor’s mission is to get rid of out-of-pocket prices as a barrier to life-saving care. There are such a lot of sufferers on the market encountering monetary misery. It has even led to the coining of a brand new time period within the medical literature, financial toxicity, to explain the issue. Our enterprise platform immediately addresses monetary toxicity by connecting sufferers with underused sources of help, which finally helps to maintain sufferers on therapy and results in higher outcomes. It additionally helps hospitals, well being techniques, and different supplier organizations to scale back the prices related to unpaid medical payments.

Ian Manners

What does your product do? How does it work?

Our core product is a patient financial assistance platform for hospitals and well being techniques. It’s an enterprise resolution targeted on serving the wants of the biggest well being techniques within the nation. Vivor is ready to combine with EHRs to proactively establish sufferers who’re eligible for numerous types of help, which reduces the haphazard nature of screening sufferers manually. Then, the platform helps employees members in managing the whole workflow of enrolling in help applications, securing funding, and reporting on the outcomes.

To make all of this potential, Vivor maintains an unlimited catalogue of affected person monetary help applications — near 2,000 in whole — together with their particulars and eligibility guidelines. Then, primarily based on a singular affected person profile together with monetary and scientific information, the software program can establish precisely the correct applications and information a employees member to take motion. Maybe extra importantly, it ties all the pieces along with options like reminders, worklists, and stories — all of that are extremely configurable so that giant techniques could make Vivor work in a manner that meets the well being system’s wants.

In some instances, massive well being techniques have chosen to pilot Vivor first at just a few preliminary websites, then develop after demonstrating worth. We adopted this strategy when partnering with Advocate Aurora Health, the place they first carried out Vivor at two hospitals earlier than increasing utilization throughout the whole well being system. Their aim was to take away obstacles to care, and implementing a constant monetary navigation course of was a key piece of the general technique.

Is that this your first healthcare startup? What’s your background in healthcare?

Beforehand, I labored in consulting for ZS Associates, a worldwide agency with a deal with fixing gross sales and advertising challenges for all times sciences corporations. It was by way of that work that I actually acquired to know the issue of rising affected person out-of-pocket prices and began brainstorming potential options. For me, healthcare can be a household enterprise: my spouse is a gynecologic oncologist, and she or he shares with me day-after-day the methods by which value and different administrative burdens make it more durable to ship one of the best look after her sufferers.

What’s your organization’s enterprise mannequin?

We use a reasonably conventional SaaS mannequin, the place our supplier prospects pay an annual subscription charge to be able to license the platform. We scale the licensing charge in response to the shopper’s total affected person quantity, however we additionally attempt to maintain it so simple as potential with no further fees for implementation, coaching, or assist.

Our ROI for suppliers is centered across the extra affected person help {dollars} that they’re able to herald through the use of Vivor. For instance, at Moffitt Most cancers Middle, certainly one of our longstanding prospects, they have been capable of safe over $1 million in incremental copay assistance through the first full yr that they have been utilizing the platform.

Moreover, Vivor companions with pharma corporations who wish to make it simpler for employees members to enroll sufferers in their very own sources like co-pay applications or affected person help applications. In these instances, we work with the producer to create an interface that we name “Express Enroll” which helps a completely digital, prompt enrollment course of.

Do you have got scientific validation in your product?

We’ve been very lucky to work over the previous a number of years with analysis companions on the Duke Most cancers Institute, particularly Dr. Yousuf Zafar, who was a part of the crew that initially coined the time period monetary toxicity within the medical literature. We acquired funding from the Nationwide Most cancers Institute to develop and take a look at a patient-facing cellular element of our expertise. In a 200-patient randomized trial, we discovered that use of Vivor’s expertise considerably elevated the probability that sufferers would apply for and safe monetary help. A few of these outcomes have already been offered at conferences just like the ASCO Annual Meeting, and the complete information has just lately been accepted for publication in JCO Oncology Apply.

To be taught extra about how Vivor is eliminating monetary obstacles in affected person care, visit our website.

Image: claudenakagawa, Getty Photos


Please enter your comment!
Please enter your name here